← Back to Search

Patient Navigator for Kidney Disease (TNT Trial)

N/A
Waitlist Available
Led By Gina Dimitropoulos, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 to 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether having a patient navigator helps young people with chronic health conditions move smoothly from child to adult healthcare. The navigator guides them through the new system, making sure they keep their appointments and follow their treatment plans. The goal is to see if this support improves their health and experience during this transition.

Eligible Conditions
  • Kidney Disease
  • Fetal Alcohol Spectrum Disorders
  • Autism Spectrum Disorder
  • Epilepsy
  • Fetal Alcohol Syndrome
  • Endocrine Disorder
  • Autoimmune Disease
  • Gastrointestinal Disorder
  • Genetic Diseases
  • Hematological Disorders
  • Cardiovascular Disease
  • Autism
  • Metabolic Diseases
  • Respiratory Diseases
  • Neurodegenerative Disease
  • Autoimmune Diseases
  • Genetic Disorders
  • Diabetes
  • Endocrine Disorders
  • Blood Diseases
  • Traumatic Brain Injury
  • Stroke

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Health services utilization
Secondary study objectives
Variation in SF-12 Scores
Variation in TRAQ (Transition Readiness Questionnaire) scores
cost analysis
Other study objectives
Youth/Caregiver Satisfaction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual Care ArmExperimental Treatment1 Intervention
Youth will receive usual care from their pediatric clinics in preparation and transfer to adult care. Participants will receive 5 issues of a provincial generic newsletter on topics around transition. Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months. Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months. Participants will be provided the opportunity to journal online about their experiences.
Group II: Patient Navigator ArmExperimental Treatment1 Intervention
Patient Navigator (Social Worker) will assist youth adapt and attach to adult delivered healthcare for up to 24 months. Participants will receive 5 issues of a provincial generic newsletter on topics around transition. Participants will be asked to complete a health questionnaire at baseline and 4 more times during 24 months. Participants will be asked to complete a transition readiness questionnaire at baseline and 4 more times during 24 months. Participants will be provided the opportunity to journal online about their experiences. Up to 100 participants will be provided the opportunity to be interviewed at baseline and end of study about their transition experience.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
808 Previous Clinical Trials
884,052 Total Patients Enrolled
University of AlbertaOTHER
936 Previous Clinical Trials
433,490 Total Patients Enrolled
Alberta Health servicesOTHER
162 Previous Clinical Trials
651,247 Total Patients Enrolled
~43 spots leftby Nov 2025